Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions are made by independently licensed clinicians based on individual health profiles. Consult a qualified healthcare professional before beginning any new treatment.

How to Evaluate a Peptide Telehealth Provider — A Practical Buyer Checklist

You want to know whether the telehealth platform asking for your credit card and health history is legitimate — or whether you're about to hand both to an operation that cuts corners. The problem is that the peptide telehealth space has grown faster than most consumers' ability to vet it, and the marketing language across platforms is nearly identical. This guide exists because Andy Palenzuela, who founded New Blue Health after 14+ years working inside regulated health product supply chains, built the kind of checklist his own team uses internally — and it's worth sharing publicly.

Why a Checklist Matters — The Current Peptide Telehealth Landscape

The peptide telehealth market has expanded rapidly since 2021, with dozens of new platforms launching each quarter. A structured evaluation checklist protects you from platforms that obscure their sourcing, inflate credentials, or bury fees. Without one, you're relying on marketing copy written specifically to prevent comparison.

Here's the reality: most platforms look similar on the surface. Clean website, stock photography of fit people, a few testimonials, and a "Get Started" button. The differences that actually matter — pharmacy sourcing, clinician independence, pricing structure, refund policies — are buried in fine print or absent entirely. Some platforms are technology and administrative services companies (like New Blue Health) that connect you with licensed clinicians and licensed pharmacies. Others are less clear about what they actually are.

A 2023 NABP (National Association of Boards of Pharmacy) report flagged thousands of online pharmacy-adjacent operations for failing to meet basic safety standards. Peptide telehealth sits in a regulatory gray zone where the barrier to launching a website is low, but the barrier to doing it correctly is high. This checklist helps you tell the difference.

Checklist Item 1 — Verify Clinician Credentials and Independence

The single most important question to ask any peptide telehealth platform: who is making the prescribing decision, and are they independently licensed? A legitimate platform uses licensed clinicians — MDs, DOs, NPs, or PAs — whose prescribing authority comes from their own state medical license, not from the platform itself.

This distinction matters more than most people realize. The platform should facilitate the connection between you and a clinician. The clinician should review your health history, evaluate contraindications, and make an independent decision about whether a prescription is appropriate. If the platform implies that everyone who signs up receives a prescription, walk away. That's not medicine — that's fulfillment.

Ask these specific questions:

• Can I verify my clinician's license through my state medical board?
• Does the clinician review my full health intake, or just a brief questionnaire?
• What happens if the clinician determines I'm not a candidate?

That last question is revealing. A platform with clinical integrity will have a clear answer. At New Blue Health, for instance, if a licensed clinician determines that a prescription is not appropriate, the patient receives a refund of their payment minus a $75 clinical consultation fee — because the clinician's time and review still occurred. If a platform can't articulate a similar policy, they may not have a real clinical review process at all.

For GLP-1 receptor agonist pathways specifically (semaglutide, tirzepatide), the clinician should be screening for medullary thyroid carcinoma (MTC), personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and history of pancreatitis. If a platform's intake form doesn't ask about these, their clinical process is inadequate. Full stop.

Checklist Item 2 — Understand Pharmacy Sourcing and Compounding Standards

Compounded medications are prepared at state-licensed 503A compounding pharmacies, not commercially manufactured. This is a critical distinction that legitimate platforms will explain clearly rather than obscure.

A 503A pharmacy operates under state board of pharmacy oversight, compounds medications pursuant to individual prescriptions, and follows USP (United States Pharmacopeia) standards — specifically USP <797> for sterile compounding and USP <795> for non-sterile compounding. You should be able to ask any platform: "Which pharmacy compounds your medications, and what standards do they follow?" If they won't answer, that's a problem.

Red flags in pharmacy sourcing include:

| Concern | What to Look For | |---|---| | Unverified regulatory claims | Platform implies commercial-grade regulatory status for compounded products | | No pharmacy identification | Platform won't name or identify the compounding pharmacy | | "Research use only" language | Peptides sold without a prescription under research chemical framing | | Overseas sourcing without disclosure | No mention of where compounding actually occurs | | No lot numbers or beyond-use dating | Medications arrive without standard pharmacy labeling |

New Blue Health publishes a compounding disclosure that explains how its pharmacy partners operate. You can also use the Compounded Source Verification Checklist to evaluate any platform's sourcing claims — including theirs. If a platform doesn't offer this level of transparency, ask yourself why.

For a deeper comparison of how legitimate peptide platforms differ from research chemical sellers, see this breakdown.

Checklist Item 3 — Demand Transparent, All-In Pricing

A trustworthy peptide telehealth platform shows you one price that includes the clinical consultation, prescription (if prescribed), medication, supplies, and shipping. Hidden fees are the most common complaint in this space, and they're entirely avoidable if you know what to ask.

Here's what all-in pricing actually looks like, using New Blue Health's published rates as a benchmark:

| Treatment | 30-Day Supply (All-In) | 90-Day Supply (All-In) | |---|---|---| | Semaglutide + B12 | $299–$524 | — | | Tirzepatide + B12 | $349–$599 | $950–$1,299 | | Sermorelin | $279 (28-day) | $679 | | Tesamorelin | $299 | $849 | | NAD+ Injectable | $249 | $549 | | PT-141 Injectable | $349 | $799 | | GHK-Cu Cream (0.2%) | $229 | — | | Glutathione Injectable | $249 | $499 |

Every price above includes the clinical consultation. There is no separate consultation fee added at checkout. This is the standard you should hold every platform to.

Be cautious of platforms that advertise a low medication price and then add a separate consultation fee, a "membership" fee, or a shipping surcharge during checkout. Ask upfront: "What is the total cost, including the clinical consultation, and are there any recurring charges I'm not seeing?"

Checklist Item 4 — Confirm State Availability and Licensing

Not every telehealth platform can serve every state. Availability depends on provider licensing, pharmacy licensing, and state-specific telehealth regulations. Any platform claiming universal coverage without qualification is either uninformed or misleading you.

New Blue Health, for example, is available in 48 states (Alabama and Mississippi excluded). That limitation exists because of specific state regulatory requirements — not because of a business decision. A platform that's honest about where it can't operate is more trustworthy than one making vague availability claims.

Before submitting payment or personal health information, confirm two things: (1) the platform is authorized to operate in your state for the specific treatment pathway you're interested in, and (2) the prescribing clinician holds an active license in your state. You can verify the latter through your state medical board's online lookup tool. Check New Blue Health's state availability page for a concrete example of how this should be disclosed.

Checklist Item 5 — Evaluate the Clinical Process (Not Just Speed)

Speed is not a quality indicator. A 48-hour turnaround that includes a thorough clinical review is better than a 2-hour turnaround that rubber-stamps every intake form.

The clinical process should follow a clear sequence: you choose a treatment pathway, complete a detailed health intake, a licensed clinician reviews your information independently, and — if appropriate — a prescription is issued and the pharmacy ships directly. That "if appropriate" qualifier is non-negotiable. Any platform that removes it, implicitly or explicitly, is prioritizing revenue over clinical integrity.

At New Blue Health, the process works exactly this way: choose a pathway, complete intake, licensed clinician reviews, and if the clinician determines a prescription is appropriate, the pharmacy ships medication, supplies, and everything needed directly. The platform itself is a technology and administrative services company, not a medical provider. Medical decisions belong to the clinician.

Questions worth asking about the clinical process:

• How long does the clinical review typically take?
• What information does the clinician review?
• Can the clinician request additional labs or follow-up before prescribing?
• Is there a mechanism for ongoing clinical oversight after the initial prescription?

Checklist Item 6 — Review Privacy, Data Handling, and HIPAA Compliance

Your health intake contains sensitive personal and medical information. The platform should be HIPAA-compliant, and it should state this explicitly — not vaguely reference "data security" without specifics.

Look for a published privacy policy that addresses how your health data is stored, who has access to it, whether it's shared with third parties for marketing purposes, and how long it's retained. If the platform uses third-party analytics tools on pages where you enter health information, that's worth scrutinizing.

LegitScript certification is another meaningful trust signal. LegitScript is an independent verification service that evaluates healthcare platforms for regulatory compliance. New Blue Health is LegitScript-certified, which means it has undergone third-party review of its business practices, pharmacy relationships, and regulatory standing. Not every platform pursues this certification — and that absence tells you something.

Checklist Item 7 — Look for Ongoing Support and Escalation Paths

What happens after you receive your medication? Can you reach someone if you have questions about your treatment? Is there a clear path to escalate a concern to a clinician?

A platform that disappears after the sale is not one you want managing your care coordination. Look for published contact information, clear response time expectations, and — critically — a way to reach clinical support if you experience an adverse reaction or have a medical question. New Blue Health publishes its contact page and maintains a safety policy that outlines escalation procedures.

Also review the platform's editorial and clinical review standards. Does it publish evidence summaries for the treatments it offers? New Blue Health maintains evidence pages for each pathway and publishes its medical review policy and evidence methodology. These aren't marketing pages — they're accountability mechanisms.

Printable Checklist Summary

Use this as a quick-reference evaluation tool for any peptide telehealth platform:

| Checklist Item | What to Confirm | Red Flag | |---|---|---| | Clinician credentials | Independently licensed MD, DO, NP, or PA; verifiable through state board | No named clinicians; promises of specific outcomes for all applicants | | Pharmacy sourcing | State-licensed 503A pharmacy; USP compliance; named pharmacy partner | Unnamed pharmacy; "research use only" language; overseas sourcing without disclosure | | Pricing transparency | Single all-in price including consultation, medication, supplies, shipping | Hidden consultation fees; membership charges added at checkout | | State availability | Clearly disclosed state restrictions; provider licensed in your state | Overstated geographic coverage; no state-specific disclosures | | Clinical process | Structured intake; independent clinician review; prescription only if appropriate | Instant approval; no health intake; no contraindication screening | | Privacy and compliance | HIPAA compliance; published privacy policy; third-party certification (e.g., LegitScript) | No privacy policy; vague "data security" claims | | Ongoing support | Published contact info; clinical escalation path; safety policy | No post-purchase support; no way to reach a clinician |

Frequently Asked Questions

What is the regulatory status of compounded peptide medications from telehealth platforms?

Compounded peptides are not commercially manufactured drugs. They are prepared at state-licensed 503A compounding pharmacies under regulatory frameworks that differ from commercially manufactured medications. A credible platform will be transparent about this distinction rather than making unverified regulatory claims. For more detail, see New Blue Health's compounding disclosure.

How do I know if a telehealth platform's clinicians are legitimate?

Look for platforms that use independently licensed clinicians — MDs, DOs, NPs, or PAs — and allow you to verify credentials through state medical board databases. Prescribing decisions should be made by the clinician based on your health history, not predetermined by the platform. If a platform implies that everyone qualifies, that is a significant red flag.

The price is all-in, with the clinical consultation included.

Reputable platforms typically show one all-in price that includes the clinical consultation, medication, supplies, and shipping. Be cautious of platforms that advertise a low base price and then add a separate consultation fee at checkout. Always ask upfront what the total cost covers before submitting payment.

Can I get peptide telehealth services in any state?

No. Availability varies by state, care pathway, pharmacy licensing, and provider licensing. Some states may not be served at all — New Blue Health, for example, is available in 48 states but does not serve Alabama or Mississippi. Always confirm that a platform operates in your state for the specific service you need before submitting payment. Check the state availability page for specifics.

What happens if the clinician decides not to prescribe?

On well-structured platforms, if a clinician determines that a prescription is not appropriate, you should receive a refund of your payment minus a non-refundable clinical consultation fee — because the clinician's review was still performed. The price is all-in, with the clinical consultation included. Ask about the refund policy before you start any intake process.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. New Blue Health is a technology and administrative services platform, not a medical provider. All prescribing decisions are made by independently licensed clinicians based on individual clinical review. Individual results vary. Compounded medications are prepared at state-licensed 503A pharmacies and are not commercially manufactured drugs.

Written by Andy Palenzuela — founder of New Blue Health, with 14+ years in regulated health product supply chains. Clinical content reviewed in accordance with New Blue Health's editorial policy by the clinical content team.